Amarin Corp Plc (AMRN)

[CaptBeer]

$AMRN Good Saturday morning my Amarin Friends. If you’ve been following along each week regarding VASCEPA® Scripts vs generic and competing PUFA’s (Lovaza-Generic), then you already know that the declining “Trend” in Total VASCEPA® scripts has reversed starting in 2023. In yesterday’s Report #29:

https://drive.google.com/file/d/1jGRI1XDhjVhNMARO7uwe0aTD6olr8VDv/view?usp=sharing

I applied a 3rd Order polynomial fit to each of the curves shown in Slide#2 shown below. Notice the dramatic upward bend to the VASCEPA® curve vs. the downward bend in the generic VASCEPA® curve. The Total Market (V+GV+GLV) and the (V+GV) curves are less dramatic but show an upward trend. Let’s hope this trend continues!